AbbVie’s tight grip on Humira market raises concerns about biosimilars

By Patrick Wingrove (Reuters) – AbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine lower-priced rivals in the U.S. in the last year, raising questions about whether the market for prescription biosimilars can survive in its current form, drug pricing experts and analysts say. Humira, which lists for…

Read More

$1.3 billion UK lawsuit accuses Amazon of misusing small sellers’ data

LONDON (Reuters) – Amazon is facing a one billion-pound ($1.3 billion) collective lawsuit from British retailers who allege that the online marketplace misused their data to boost its own market share and profits. The British Independent Retailers Association (BIRA), an umbrella body grouping numerous small traders, was due to file the lawsuit on behalf of…

Read More

US may revive some shut nuclear plants to help meet emissions goal, energy chief says

By Timothy Gardner WASHINGTON (Reuters) – The United States could revive some of its recently retired nuclear power plants to help meet rising demand for zero-emissions electricity, or add reactors to existing sites, Energy Secretary Jennifer Granholm said in an interview. The administration of President Joe Biden believes nuclear power is critical to meeting greenhouse…

Read More